Related Experiment Video
Updated: Aug 16, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection
Dana S Hardin1, Julie Rice, Marilyn E Doyle
1University of Texas-South-western Medical School, Dallas, TX, USA. dana.hardin@utsouth-western.edu
Insights
Human growth hormone (GH) therapy significantly improved linear growth and lean tissue mass in children with human immunodeficiency virus (HIV). GH also reduced protein catabolism without increasing viral load.
Area of Science:
- Pediatrics
- Endocrinology
- Infectious Diseases
Background:
- Children with human immunodeficiency virus (HIV) often experience poor linear growth and weight loss.
- Loss of lean tissue mass (LTM) and accelerated protein catabolism are common in HIV-infected individuals.
Purpose of the Study:
- To evaluate the effect of human recombinant growth hormone (GH) on linear height in HIV-infected children.
- To determine if GH therapy can reverse protein catabolism in this population.
Main Methods:
- Six HIV-infected children were studied over 6 months.
- Protein turnover was assessed using 1-[(13)C] leucine stable isotope.
- Body composition (LTM) was measured by dual X-ray absorptiometry (DXA).
Main Results:
- Growth velocity increased from 3.9 cm/year to 7.9 cm/year after 6 months of GH therapy.
- Protein catabolism significantly decreased, and LTM significantly improved in all subjects.
- No significant increase in viral burden was observed during GH treatment.
Conclusions:
- GH therapy is effective in improving height and weight in HIV-infected children.
- GH reduces protein catabolism without adversely affecting viral burden.
- Recombinant GH is a potential therapeutic option for growth failure in pediatric HIV.
Introduction:
Poor linear growth and weight loss are well documented in children with human immunodeficiency virus (HIV) infection and past studies in adults and children have reported that loss of lean tissue mass (LTM) associated with accelerated rates of protein catabolism. We undertook this study to test the hypothesis that human recombinant GH would improve linear height in HIV-infected children. Our second goal was to determine if GH could reverse protein catabolism in HIV-infected children.
Methods:
We studied six HIV-infected children (mean age 9.2 years, Tanner stage I, CD4 counts 110 000--292 000, two girls, four boys). Measures of protein turnover were conducted using the stable isotope 1-[(13)C] leucine. Body composition was measured by dual X-ray absorptiometry (DXA) scan for determination of LTM. Viral burden and IGF-1 levels were measured. Studies were conducted at baseline and 6 months.
Results:
The baseline growth velocity of these children was only 3.9 cm/year. After 6 months of GH, growth velocity increased to 7.9 cm/year. Protein catabolism, represented as leucine rate of appearance (Ra) in the fasted state, was high at baseline, but decreased significantly after 6 months of GH therapy. Lean tissue mass significantly improved in all subjects. Viral burden did not increase significantly in any subject during GH therapy.
Conclusion:
These results suggest that GH improves height and weight and reduces protein catabolism in HIV-infected children without negative effect on viral burden.
Related Concept Videos
Nature and Nurture
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Cellular Adaptation II: Hypertrophy
Inhibitors of Virion Maturation and Assembly
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
